hcplive.com
VIVID Post Hoc Analysis Supports Mirikizumab After Anti-TNF Failure in Crohn's Disease
Cure8 flagged this item because the article title and available source metadata connect it to Crohn's disease, Inflammatory bowel disease, Mirikizumab, and Anti-TNF. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Clinicians and Patients On Biologics following Crohn's disease, Inflammatory bowel disease, Mirikizumab, Anti-TNF, and IL-23 inhibitor.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, Mirikizumab, and Anti-TNF. Use the original source link for the full details.
Study details such as design, patient population, comparison group, and measured outcomes matter. The original source has the full context.
